Prosecution Insights
Last updated: April 19, 2026
Application No. 18/339,584

CATHETER ASSEMBLY AND USE METHOD

Non-Final OA §103
Filed
Jun 22, 2023
Examiner
HOLWERDA, KATHLEEN SONNETT
Art Unit
3771
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Terumo Kabushiki Kaisha
OA Round
3 (Non-Final)
69%
Grant Probability
Favorable
3-4
OA Rounds
3y 9m
To Grant
85%
With Interview

Examiner Intelligence

Grants 69% — above average
69%
Career Allow Rate
652 granted / 949 resolved
-1.3% vs TC avg
Strong +17% interview lift
Without
With
+16.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 9m
Avg Prosecution
55 currently pending
Career history
1004
Total Applications
across all art units

Statute-Specific Performance

§101
0.2%
-39.8% vs TC avg
§103
43.5%
+3.5% vs TC avg
§102
25.5%
-14.5% vs TC avg
§112
21.2%
-18.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 949 resolved cases

Office Action

§103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 12/8/2025 has been entered. Response to Arguments Applicant’s arguments with respect to the claim(s) have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. Claim Objections Claims 10 and 11 are objected to because of the following informalities: Claim 10: “0.36 mmm” should read “0.36 mm.”. Claim 11: “the distal end of the second shaft” bridging lines 15-16 should read “[[the]] a distal end of the second shaft” as this is its first recitation. Appropriate correction is required. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1-2, 4, 6-13, and 15 is/are rejected under 35 U.S.C. 103 as being unpatentable over Patterson (US 5,391,152) in view of Hayakawa et al. (US 2020/0023168). Regarding claims 1 and 11, Patterson discloses a catheter assembly (fig. 1) comprising: a first catheter comprised of a first shaft (21) that includes a distal end and a proximal end at opposite axial ends of the first shaft, the first shaft including a first distal end opening at the distal end of the first shaft and a first proximal end opening at the proximal end of the first shaft, the first catheter including a first lumen (26) extending between the first distal end opening and the first proximal end opening (fig. 1, 6); a second catheter (31; fig. 1) comprised of a second shaft that includes a distal end and a proximal end at opposite axial ends of the second shaft, the second shaft including a second distal end opening at the distal end of the second shaft and a second proximal end opening at the proximal end of the second shaft, the second catheter including a second lumen (36) extending between the second distal end opening and the second proximal end opening (fig. 1), the second catheter including a second hub (35) at the proximal end of the second shaft and communicating with the second lumen, the second catheter (31) having both an outer diameter and an inner diameter at the second distal end opening; the first catheter positioned in the second lumen of the second shaft and configured to be axially positionable relative to the second shaft such that a distal portion of the first shaft extends distally beyond the distal end of the second shaft (fig.1); a guidewire (not illustrated, but disclosed in col. 1, ll. 30-40) located in the first lumen in the first shaft. The first shaft (21) of Patterson has a first wall thickness “T1” ((outer diameter – inner diameter)/2) at a position of the second distal end of the second shaft, and the second shaft (31) of Patterson has a second wall thickness “T2” ((outer diameter – inner diameter)/2). Although Patterson does not disclose the exact wall thicknesses of the first and second catheters, the first wall thickness of the first catheter (21) is illustrated as being greater than the second wall thickness of the second catheter (31) in fig. 1 of Patterson, and thus one skilled in the art would have found it obvious to construct the first catheter 21 with a greater wall thickness than that of the second catheter 31 as suggested by the relative dimensions illustrated in figure 1. The first inner diameter of the first catheter (21) is constant between the first distal opening and the first proximal end opening of the first catheter as illustrated in figure. 1, noting that the taper of 22 is only formed in the outer wall as understood in view of fig. 1 of Patterson. Patterson is silent on the clearance between an inner surface of the second shaft and an outer surface of the first shaft at the second distal opening when the first catheter is positioned in the second lumen of the second shaft and the distal portion of the first shaft extends distally beyond the distal end of the second shaft. Hayakawa discloses another catheter assembly comprising a first (inner) catheter (40; fig. 1) having a tapered tip that is coaxially located within a second (outer) catheter (51), the first catheter having a wall thickness greater than the second catheter (as illustrated in fig. 2 and 4; see also [0075], [0081]). Hayakawa further discloses that the clearance between an inner surface of the second shaft and an outer surface of the first shaft at the second distal end opening when the first catheter is positioned in the second lumen and the distal portion of the second shaft is 0.1mm to 0.5mm ([0081]). Hayakawa further discloses ranges of thicknesses for the first and second catheters (T1 and T2, respectively), wherein the clearance CL is not equal to T1 or T2 (noting claimed ranges only require that CL is not equal to T1 or T2, but could be less than both T1 and T2, greater than both T1 and T2, or between T1 and T2). It would have been obvious to one of ordinary skill in the art to modify the size of the first and second catheters of Patterson such that the clearance between the inner surface of the second shaft and the outer surface of the first shaft is greater than 0.1 mm and less than or equal to 0.35 mm, the clearance being a value other than T1 or T2, in view of Hayakawa’s teaching of clearances between 0.1 and 0.5mm (that may be unequal to either wall thickness) being known and suitable for coaxial catheters, since it has been held that “[i]n the case where the claimed ranges ‘overlap or line inside ranges disclosed by the prior art’ a prima facie obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990). Regarding claims 2 and 12, the first shaft (21) has a tapered distal end (22; fig.1 of Patterson). Regarding claim 4, the distal end of the second shaft includes a curved or bent portion (noting second catheter 31 is cylindrical, the distal end includes a curved portion, the curve defined by the outer surface of the cylinder) Regarding claim 6 and 15, Patterson does not expressly disclose the distance between the first and second distal end openings, though it is noted that the first and second catheters are slidable relative to each other such that the distance can be adjusted. It would have been obvious to one of ordinary skill in the art to have modified Patterson to dimension the first and second catheters such that the distance between their distal end openings is between 10mm to 200mm, since it has been held that “where the only difference between the prior art and the claims was a recitation of relative dimensions of the claimed device and a device having the claimed dimensions would not perform differently than the prior art device, the claimed device was not patentably distinct from the prior art device” Gardner v. TEC Syst., Inc., 725 F.2d 1338, 220 USPQ 777 (Fed. Cir. 1984, cert. denied, 468 U.S. 830, 225,SPQ 232 (1984). Regarding claims 7 and 15, it would have been obvious to one of ordinary skill in the art to modify the clearance of Patterson in view of Hayakawa from between 0.1 mm and 0.5 mm to greater than or equal to 0.15 mm and less than or equal to 0.3 mm since it has been held that “[i]n the case where the claimed ranges ‘overlap or line inside ranges disclosed by the prior art’ a prima facie obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990). Regarding claims 8-10, Patterson discloses a guidewire (not illustrated, but disclosed in col. 1, ll. 30-40) configured to be received in the first lumen of the first shaft. This guidewire can be considered an “angiographic” guide wire or a “therapeutic” guidewire as these terms are drawn to the intended use of the guidewire. Because the guidewire of Patterson in view of Hayakawa can be used during an angiographic procedure or during a therapeutic procedure, it meets this intended use recitation. Further regarding claims 9 and 10, Patterson does not expressly disclose the size of the guidewire. However, Hayakawa teaches that the guidewire (10) may have a shaft portion (12) having an outer diameter of 0.3 to 1.0mm ([0051]), which encompasses the claimed values of 0.36mm and 0.89mm, thereby rendering them obvious since it has been held that “[i]n the case where the claimed ranges ‘overlap or line inside ranges disclosed by the prior art’ a prima facie obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990). Regarding claim 13, the second catheter (31) of Patterson is a guiding catheter having a distal tip configured to introduce a treatment catheter (noting catheter 21 can be removed and a treatment catheter may be placed within catheter 31, which guides the treatment catheter through puncture opening). Claim(s) 3 is/are rejected under 35 U.S.C. 103 as being unpatentable over Patterson in view of Hayakawa as applied to claim 1 above and further in view of Lennon et al. (US 2016/0000499). Patterson in view of Hayakawa disclose the invention substantially as stated above including that the second catheter (31) is a guiding catheter having a distal tip configured to introduce a treatment catheter (noting dilator 21 can be removed and a treatment catheter may be placed within catheter 31, which guides the treatment catheter through puncture opening), but fails to expressly disclose that the distal tip includes a reinforcing body. Lennox discloses another catheter assembly comprising a second (outer) catheter (15/76; fig. 9) coaxial with a first (inner) catheter (62). Lennox discloses that the tip of the second catheter includes a thin-walled ring of radiopaque metal (77; [0141]). As understood by one of ordinary skill in the art, such a marker facilitates visualization of the distal end of the second catheter once it is placed in the body. It would have been obvious to one of ordinary skill in the art to have modified the prior art of Patterson to include a thin-walled ring of radiopaque metal at the distal tip of the second catheter as taught by Lennox in order to allow visualization of the distal end of the second catheter while it is inserted into a patient’s body. The metal ring can be considered a reinforcing body since it reinforces the polymeric tip as compared to a similar polymeric tip having no metal ring. Claim(s) 5 and 14 is/are rejected under 35 U.S.C. 103 as being unpatentable over Patterson in view of Hayakawa as applied to claims 4 and 11 above and further in view of Whiting et al. (US 2006/0009737). Patterson does not expressly disclose that the distal end of the second shaft has a Judkins shape. Whiting discloses another catheter assembly (fig. 1) and further teaches that the outer guiding catheter (12) of the catheter assembly can have a Judkins shape ([0027]), which is useful depending on the initial access point for the procedure on the patient. It would have been obvious to one of ordinary skill in the art to have modified the distal end of the second shaft of Patterson to have a Judkins shape in view of Whiting’s teaching that such a shape is useful as a guiding catheter depending on the initial access point. Claim(s) 16 is/are rejected under 35 U.S.C. 103 as being unpatentable over Patterson in view of Hayakawa as applied to claim 11 above and further in view of Schuermann (US 2016/0175501). Patterson in view of Hayakawa discloses the invention substantially as stated above including a guidewire received in the first lumen of the first shaft, but fails to expressly disclose a second guidewire configured to be received in the first lumen of the first shaft. Schuermann discloses that a kit comprising a cannula (20) and a guidewire (30) configured to be received in a lumen of the cannula. Schuermann further discloses that the kit can comprise multiple guidewires having various lengths in order to accommodate the type of approach desired by an operator (e.g., transaortic versus transfemoral: [0022]). It would have been obvious to one of ordinary skill in the art to have further modified the prior art of Patterson in view of Hayakawa to include at least a second guidewire having a different length than the first guidewire, the second guidewire configured to be received by the first lumen in the first shaft, in view of Schuermann such that the operator may choose a guidewire having a length best suited for the approach desired by the operator. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to KATHLEEN SONNETT HOLWERDA whose telephone number is (571)272-5576. The examiner can normally be reached M-F, 8-5, with alternate Fridays off. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Elizabeth Houston can be reached at 571-272-7134. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. KSH 1/7/2026 /KATHLEEN S HOLWERDA/Primary Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

Jun 22, 2023
Application Filed
May 22, 2025
Non-Final Rejection — §103
Aug 21, 2025
Response Filed
Sep 08, 2025
Final Rejection — §103
Dec 08, 2025
Request for Continued Examination
Dec 20, 2025
Response after Non-Final Action
Jan 08, 2026
Non-Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12594096
SYSTEMS AND METHODS FOR ENHANCED IMPLANTATION OF ELECTRODE LEADS BETWEEN TISSUE LAYERS
2y 5m to grant Granted Apr 07, 2026
Patent 12588908
Independent Gripper
2y 5m to grant Granted Mar 31, 2026
Patent 12582431
SURGICAL INSTRUMENT WITH SELECTOR
2y 5m to grant Granted Mar 24, 2026
Patent 12564459
ACTIVE DRIVES FOR ROBOTIC CATHETER MANIPULATORS
2y 5m to grant Granted Mar 03, 2026
Patent 12551657
CUSTOM LENGTH STYLET
2y 5m to grant Granted Feb 17, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
69%
Grant Probability
85%
With Interview (+16.7%)
3y 9m
Median Time to Grant
High
PTA Risk
Based on 949 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month